达普罗德斯塔特:在脏贫血治疗中的潜在游戏改变者-一个前景
Muhammad Usman Haider1, Muhammad Furqan1, Qasim Mehmood1
1Department of Medicine, King Edward Medical University, Lahore, Punjab, Pakistan.
Frontiers in pharmacology
|August 28, 2023
概括
美国食品和药物管理局批准了达普罗杜斯塔特,这是一种新的口服治疗慢性病 (CKD) 透析患者的贫血. 临床试验证实了其有效性,安全性和减少静脉铁使用的潜力,为CKD贫血管理提供了显著的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 贫血是慢性病 (CKD) 的常见并发症.
- 目前的CKD相关贫血治疗方法通常涉及注射,例如红色素形成刺激剂 (ESA) 和静脉注射 (IV) 铁.
- 口服治疗选择有限,特别是对于透析患者.
研究的目的:
- 评估达普罗多斯塔特 (DPD) 作为治疗慢性脏病患者接受透析的贫血的口服治疗的疗效和安全性.
- 为了比较DPD与现有的注射治疗方法,如 darbepoetin.
- 探索DPD在非透析CKD患者和并发性心力衰竭患者中的潜力.
主要方法:
- 进行了临床试验,以评估DPD在提高和维持血红蛋白水平方面的有效性.
- 严格监测安全情况,包括不良事件和需要输血的情况.
- 进行了与标准注射ESA的darbepoetin进行比较,并进行了IV铁利用率的评估.
主要成果:
- 在透析患者中,达普罗杜沙特在治疗慢性病的贫血方面表现为与达布罗丁相比不劣.
- DPD显示出良好的安全性,与现有治疗方法相比.
- 有证据表明,使用DPD可能会减少对静脉注射铁补充剂的需求.
结论:
- 美国FDA对达普罗杜斯塔特的批准标志着一个重要的里程碑,作为CKD中透析相关贫血的第一个口服疗法.
- DPD为注射治疗提供了一个方便和有效的替代方案,有可能改善患者的坚持和生活质量.
- 需要进行进一步的研究,以充分阐明DPD在非透析CKD患者和患有心脏带病的患者中的作用.
更多相关视频
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
8.5K
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
853
相关概念视频
01:11Renal Failure: Dose Adjustments
120
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
120
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
01:30Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54
01:25Antihypertensive Drugs: Direct Renin Inhibitors
679
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
679
01:15Renal Drug Excretion: Overview
183
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
183
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463